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here we are together again, in Jasper, Alberta. Thanks to the soci-
ety for allowing me to discuss this paper. Congratulations to
Dr Candell on a nice presentation.
I had several initial impressions when reading this manuscript.
Much like some of the work from the Vascular Study Group of
New England, and actually with a co-author from a member of
the VSGNE, we have yet another example of a large Integrated
Regional Health Care System collecting their experience to pro-
vide a large number of patients and present information that would
potentially help guide therapy. Unfortunately, I don’t feel as if this
study really adds much to what we already know.
There were 1736 patients treated with endovascular aortic
aneurysm repair (EVAR) over a 10-year period at 17 Kaiser sites.
When you do the math, that is 10 EVARs per year per site e a
modest experience at best. Delayed rupture occurred in only 20
patients, with six of those patients being treated for rupture or
symptoms to begin with. That left only 15 patients with delayed
rupture after 30 days for an incidence of 0.8%. So, we know that
this is indeed a rare event! We also see that patients who experi-
enced delayed rupture were old and the majority of their sacs
increased in size over time, leading to multiple reinterventions.The authors sought to deﬁne what factors, if any, contributed to
this rare event.
Sadly, no data on device, instructions for use (IFU) adher-
ence, oversizing, or anatomical suitability features were collected.
All we can gather from this data set is that old age and rupture
at presentation were associated with increased risk of delayed
rupture. We already knew that!
The conclusion is that we need to follow our patients and be
diligent. Okay. So, does that mean that you’re not going to treat
old people or those presenting with rupture? Thankfully, according
to this dataset, 99% of patients will not experience this morbid and
potentially mortal event.
Another interesting ﬁnding from this decade-long experience
was that no ruptures were due to type II endoleaks, sustaining our
belief that most type IIs are benign AND when associated with an
increase in sac size, probably really aren’t type IIs and are more
likely types I and III.
So, I have the following three questions for the authors:
1. How will this information be used to change practice within
the Kaiser system? After all, isn’t that why we do these studies?
Is this outcome data available to ALL vascular interventionists
within the Kaiser system?! In other words . how does this
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she can change his or her own practice?
2. With an average of only 10 EVARs per site per year, has there
been any discussion about regionalization of care for EVAR in
Northern California? Were some event rates higher at certain
sites suggesting treatment outside of device IFUs by some
“aggressive” physicians? Three of 15 delayed rupture patients
had additional procedures at the index operation including
snorkels and cuffs for type I endoleaks; this suggests that treat-
ment outside the device IFU for short neck aneurysms was
associated with a higher delayed rupture event rate.
3. Finally, you must tell us what the graft types and anatomical
features were for all that had delayed rupture. It is astonishing
to me that these data were not reported with Kaiser’s reputa-
tion of such a thorough electronic medical record! Come on,
guys; it’s only 20 patients! I realize that you don’t have this
information, but this would indeed be useful data. What was
the frequency of delayed rupture over time? Has this decreased
over the past decade in the authors’ experience?
Thank you for sending me the manuscript at least 1 week
before the meeting, and I look forward to your comments.
Dr Leah Candell. Thank you, Dr Starnes, for your interesting
comments, which speak to many issues regarding a retrospective
registry. It is our goal to understand outcomes within our inte-
grated health system. In order to do so, we must improve our
data acquisition to inform our conclusions.
With respect to your ﬁrst comment about the modest experi-
ence across facilities: in Kaiser Permanente’s early experience with
EVAR, sites and clinicians were clustered around the neighboring
academic centers. As experience was gained, the case volume and
number of operating surgeons increased greatly throughout the
second half of the study period. This is reﬂected in the mean
follow-up of 2.7 years despite our 10 years of experience.
Second, our device registry, created more than a decade ago,
did not require anatomic information to be collected other than
abdominal aortic aneurysm size. Although we had some promising
data about IFU adherence from a subset of patients, this was by nomeans standard and comprehensive, which limited our ability to
analyze this important topic. This is something we will address
with our new national stent registry.
We appreciate your comments about the observation of type II
leaks, and we agree that they may represent a benign occurrence
after EVAR. We looked into this in more detail and presented
these ﬁndings at the VESS meeting in Boston, in June 2014.
Our responses to your three speciﬁc questions follow:
1. We agree that registry information should be used for practice
improvement. This is central to any system’s mission to pro-
vide efﬁcient and safe care. Currently, Kaiser Permanente reg-
istry reports are tabulated quarterly with several outcomes
reported at the national, regional, and more granular levels.
In addition, clinicians may request a breakout report of certain
characteristics or outcomes. Similar to what is done in other
registry domains, we are utilizing this ability to establish
more-efﬁcient surveillance protocols, to more appropriately
select patients for intervention, and to improve processes
such as percutaneous access.
2. As stated above, currently most sites that perform EVAR have
higher operative volumes than they did in the early era of
EVAR. There has been an evolution into a spoke-hub model
in which complex thoracic and abdominal aortic interventions
are performed in a few selected centers. This is certainly true
with the hybrid endovascular procedures as well as fenestrated
EVAR.
3. We agree that information on graft type and anatomical fea-
tures is vital for understanding the rare phenomenon of
delayed rupture. This content was removed from the original
manuscript due to privacy concerns, but after further discus-
sion, was added into the ﬁnal manuscript that will be pub-
lished. The limited availability of archived computed
tomography data allowed us to make only general statements
about IFU adherence and was not sufﬁcient to enable us to
comment on graft and anatomic interactions.
We thank Dr Starnes for his review of our paper and his
thoughtful comments.
